Pioneering research led by Brazilians describes the immune system's reactions in detail in the first living patient to receive a genetically modified ...

Achieved 98% manufacturing batch success rate at BaseCamp across cell therapy, viral vector, and mRNA – Positioned U.S.-based biomanufacturing hub to supply genetic medicine products across North ...

Researchers at the University of Waterloo have developed a new way to tackle one of the world’s most persistent forms of ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50.

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

A research team has delivered a comprehensive overview showing how microbial fermentation—guided by synthetic biology, metabolic engineering, and smart bioprocess design—can transform violacein from a ...

A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

According to results from the 11 centres, Rakib secured 1,142 votes, while his closest rival, Shibir-backed VP candidate ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young adults under the age of 50 ...

Rather than yeast or microalgae, the company is working with oleaginous bacteria—which it claims are more productive.